TP53 and autoimmune disease: Another miRNA, miR-192 affecting cellular proliferation through the p53 pathway, has been reported to be down-regulated in systemic lupus erythematosus, an autoimmune disease inducing inflammatory responses (Wang et al. 2011) and in asthmatic subjects upon an allergen inhalation challenge (Yamamoto et al. 2012).